$CELZ- The Russia PromoMed deal will catapult the global growth. Looking forward to their follow-up on the 2 patients treated with CAVERSTEM in October. If results from those patients are as expected, things will begin to move quickly. And if the Minister of Urology gets insurance to cover a strong portion or all of the procedure, well then the millions of men suffering from ED in Russia will be running to get the treatment done.
I expect CMTH/CELZ revenue to really take off in 2019 and have 5M shares holding until at least May to see the revenue progression.
News 
Market Data 
Discover 
